HQH vs. HTGC, DNP, ADX, PTY, USA, NUV, GSBD, GAB, TY, and RVT
Should you be buying Abrdn Healthcare Investors stock or one of its competitors? The main competitors of Abrdn Healthcare Investors include Hercules Capital (HTGC), DNP Select Income Fund (DNP), Adams Diversified Equity Fund (ADX), PIMCO Corporate & Income Opportunity Fund (PTY), Liberty All-Star Equity Fund (USA), Nuveen Municipal Value Fund (NUV), Goldman Sachs BDC (GSBD), The Gabelli Equity Trust (GAB), Tri-Continental (TY), and Royce Value Trust (RVT). These companies are all part of the "investment offices, not elsewhere classified" industry.
Hercules Capital (NYSE:HTGC) and Abrdn Healthcare Investors (NYSE:HQH) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability, risk and community ranking.
Hercules Capital has a net margin of 69.98% compared to Hercules Capital's net margin of 0.00%. Abrdn Healthcare Investors' return on equity of 18.35% beat Hercules Capital's return on equity.
Hercules Capital presently has a consensus price target of $18.56, indicating a potential downside of 6.23%. Given Abrdn Healthcare Investors' higher probable upside, research analysts plainly believe Hercules Capital is more favorable than Abrdn Healthcare Investors.
Hercules Capital has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500. Comparatively, Abrdn Healthcare Investors has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500.
Hercules Capital received 340 more outperform votes than Abrdn Healthcare Investors when rated by MarketBeat users. However, 65.08% of users gave Abrdn Healthcare Investors an outperform vote while only 64.22% of users gave Hercules Capital an outperform vote.
In the previous week, Hercules Capital had 7 more articles in the media than Abrdn Healthcare Investors. MarketBeat recorded 8 mentions for Hercules Capital and 1 mentions for Abrdn Healthcare Investors. Hercules Capital's average media sentiment score of 1.67 beat Abrdn Healthcare Investors' score of 1.29 indicating that Abrdn Healthcare Investors is being referred to more favorably in the news media.
19.7% of Hercules Capital shares are owned by institutional investors. Comparatively, 32.6% of Abrdn Healthcare Investors shares are owned by institutional investors. 1.9% of Hercules Capital shares are owned by company insiders. Comparatively, 7.3% of Abrdn Healthcare Investors shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Hercules Capital has higher revenue and earnings than Abrdn Healthcare Investors.
Hercules Capital pays an annual dividend of $1.60 per share and has a dividend yield of 8.1%. Abrdn Healthcare Investors pays an annual dividend of $1.85 per share and has a dividend yield of 10.9%. Hercules Capital pays out 72.7% of its earnings in the form of a dividend.
Summary
Hercules Capital beats Abrdn Healthcare Investors on 9 of the 16 factors compared between the two stocks.
Get Abrdn Healthcare Investors News Delivered to You Automatically
Sign up to receive the latest news and ratings for HQH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HQH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Abrdn Healthcare Investors Competitors List
Related Companies and Tools
